Research Topics
| Linda WeissSummaryAffiliation: New York Academy of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
A vulnerable population in a time of crisis: drug users and the attacks on the World Trade CenterLinda Weiss
Office of Special Populations, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
J Urban Health 79:392-403. 2002..Other participants were essentially forced to limit use by marked reductions in income. For others, access to health and social service professionals, as well as drug treatment, proved to be key...
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatmentLinda Weiss
The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
J Acquir Immune Defic Syndr 56:S7-13. 2011..Although limitations to evaluation findings persist, they may be balanced by the scope and "real-world" context of the initiative...- Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborativeLinda Weiss
The New York Academy of Medicine, Center for Evaluation and Applied Research, New York, NY 10029, USA
J Acquir Immune Defic Syndr 56:S68-75. 2011..The experiences of physicians leading the Buprenorphine HIV Evaluation and Support initiative provides valuable information for other HIV providers seeking to integrate medication-assisted treatment services into HIV clinical care... - Access to multilingual medication instructions at New York City pharmaciesLinda Weiss
Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, USA
J Urban Health 84:742-54. 2007..Pharmacists should post signs and make other efforts to inform patients about the language resources available to them... - Defining neighborhood boundaries for urban health researchLinda Weiss
Office of Special Populations, New York, New York 10029, USA
Am J Prev Med 32:S154-9. 2007.... 
Adherence to HAART: perspectives from clients in treatment support programsLinda Weiss
Office of Special Populations, The New York Academy of Medicine, New York, NY 10029, USA
Psychol Health Med 11:155-70. 2006..Educational, practical, and supportive services were all considered valuable to clients participating in adherence support programs. A mix of services may best meet the range of needs found among persons taking HAART...- HIV-related knowledge and adherence to HAARTL Weiss
Office of Special Populations, New York Academy of Medicine, NY 10029, USA
AIDS Care 15:673-9. 2003..Similarly, providers should be diligent with respect to patient education, ensuring that each patient has the information needed to support reasoned decision making and adequate adherence... - Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York CityMicaela H Coady
Center for Urban Epidemiological Studies at the New York Academy of Medicine, New York, NY, USA
Am J Public Health 98:1314-21. 2008..We sought to determine whether the work of a community-based participatory research partnership increased interest in influenza vaccination among hard-to-reach individuals in urban settings... - The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman
Department of Public Health, Weill Cornell Medical College, New York, NY 10065, USA
J Acquir Immune Defic Syndr 56:S76-82. 2011..Implementing integrated HIV and buprenorphine/naloxone treatment requires cost estimates to plan and obtain funding... - Sampling and recruitment in multilevel studies among marginalized urban populations: the IMPACT studiesDanielle C Ompad
Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029 5283, USA
J Urban Health 85:268-80. 2008..quot; We describe the organization and rationale for the IMPACT Studies in New York City as a case illustration on how such issues may be addressed... - Patient perspectives on buprenorphine/naloxone treatment in the context of HIV careJames E Egan
The New York Academy of Medicine, Center for Evaluation and Applied Research, 1216 5th Avenue, New York, NY 10029, USA
J Acquir Immune Defic Syndr 56:S46-53. 2011..Research has shown that buprenorphine/naloxone (bup/nx) is a safe and effective treatment for opioid dependence. Few reports, however, describe the patient perspective on bup/nx treatment and its integration into HIV care settings... - "Just like I'm saving money in the bank": client perspectives on care coordination servicesMaysoun Freij
Center for Evaluation and Applied Research, New York Academy of Medicine, New York, New York 10029, USA
J Gerontol Soc Work 54:731-48. 2011..Disparities in access to care coordination appear to remain for immigrant, minority and suburban populations... - The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatmentJames E Egan
New York Academy of Medicine, 1216 5th Avenue, New York, NY 10029, USA
J Gen Intern Med 25:936-41. 2010..The PCSS-B model provides support for a mentorship program to assist non-specialty physicians in the provision of buprenorphine and may serve as a model for dissemination of other types of care... - Factors affecting willingness to provide buprenorphine treatmentJulie Netherland
The New York Academy of Medicine, Division of Health Policy, New York, NY 10029, USA
J Subst Abuse Treat 36:244-51. 2009..These data provide important insight into physician concerns about buprenorphine and have implications for practice, education, and policy change that may effectively support widespread adoption of buprenorphine... - Predictors of influenza vaccination in an urban community during a national shortageErica Phillips-Caesar
Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
J Health Care Poor Underserved 19:611-24. 2008..Such groups are less likely to be vaccinated when vaccines are scarce... - Paradigm shifters, professionals, and community sentinels: immigrant community institutions' roles in shaping places and implications for stigmatized public health initiativesJohn J Chin
Department of Urban Affairs and Planning, Hunter College, The City University of New York, New York, NY 10065, USA
Health Place 14:866-82. 2008..Implications are explored for working with immigrant community institutions to conduct HIV-related work and other stigmatized public health initiatives in immigrant neighborhoods... - Rapid vaccine distribution in nontraditional settings: lessons learned from project VIVAMicaela H Coady
Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY 10029, USA
J Community Health Nurs 24:79-85. 2007..In conclusion, this project may be replicated in other communities and utilized for annual vaccination campaigns and in the event of a pandemic... - Chinese and South Asian religious institutions and HIV prevention in New York CityJohn J Chin
Office of Special Populations, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA
AIDS Educ Prev 17:484-502. 2005.... - Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration projectJames Tesoriero
AIDS Institute, New York State Department of Health, Menands, New York 12204, USA
J Acquir Immune Defic Syndr 33:484-93. 2003..Findings illustrate the importance of multiple, periodic assessments of adherence and the need to consider strategies to increase stability in the factors affecting adherence to HAART... - Correlation of a brief perceived stress measure with nonadherence to antiretroviral therapy over timeTyler French
AIDS Institute, New York State Department of Health, Menands, NY, USA
J Acquir Immune Defic Syndr 38:590-7. 2005.... - Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifenHyman B Muss
Vermont Cancer Center, University of Vermont College of Medicine, Burlington, Vermont 05401, USA
Breast J 13:337-45. 2007..In this trial, HER-2 and CD1 proved of borderline significance as predictive factors for recurrence on tamoxifen. An SVM model that included all clinical and biologic variables correctly predicted relapse in >75% of patients... - Do thyroid disorders increase the risk of breast cancer?Michael S Simon
Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
Cancer Epidemiol Biomarkers Prev 11:1574-8. 2002..There was no statistical interaction between thyroid disorders, thyroid treatments, and race, menopausal status, or parity. We found no association between thyroid disorders or their associated treatments and the risk of breast cancer... - Ethics and trusteeship for health care. Hospital Board Service in Turbulent TimesBruce Jennings
Hastings Cent Rep 32:Suppl S1-24. 2002